scholarly journals H662 is the linchpin of ATP hydrolysis in the nucleotide-binding domain of the ABC transporter HlyB

2005 ◽  
Vol 24 (11) ◽  
pp. 1901-1910 ◽  
Author(s):  
Jelena Zaitseva ◽  
Stefan Jenewein ◽  
Thorsten Jumpertz ◽  
I Barry Holland ◽  
Lutz Schmitt
Author(s):  
Ljuvica Kolich ◽  
Ya-Ting Chang ◽  
Nicolas Coudray ◽  
Sabrina I. Giacometti ◽  
Mark R. MacRae ◽  
...  

ABC transporters facilitate the movement of a diverse array of molecules across cellular membranes, using power from ATP hydrolysis. While the overall mechanism of the transport cycle has been characterized in detail for several important members of this transporter family, it is less well understood how the activity of ABC transporters is regulated in the cell post-translationally. Here we report the X-ray crystal structure of MlaFB from E. coli, an ABC nucleotide binding domain (MlaF) in complex with its putative regulatory subunit (MlaB). MlaFB constitutes the cytoplasmic portion of the larger MlaFEDB ABC transporter complex, which drives phospholipid transport across the bacterial envelope and is important for maintaining the integrity of the outer membrane barrier. Our data show that the regulatory subunit MlaB, a STAS domain protein, binds to the nucleotide binding domain and is required for its stability. Our structure also implicates a unique C-terminal tail of the ABC subunit, MlaF, in self-dimerization. Both the C-terminal tail of MlaF and the interaction with MlaB are required for the proper assembly of the MlaFEDB complex and its function in cells. This work leads to a new model for how the activity of an important bacterial lipid transporter may be regulated by small binding proteins, and raises the possibility that similar regulatory mechanisms may exist more broadly across the ABC transporter family, from bacteria to humans.


Biochemistry ◽  
2014 ◽  
Vol 53 (46) ◽  
pp. 7148-7159 ◽  
Author(s):  
T. Reid Alderson ◽  
Jin Hae Kim ◽  
Kai Cai ◽  
Ronnie O. Frederick ◽  
Marco Tonelli ◽  
...  

2007 ◽  
Vol 28 (5) ◽  
pp. 1841-1850 ◽  
Author(s):  
Zhengmao Ye ◽  
John D. Lich ◽  
Chris B. Moore ◽  
Joseph A. Duncan ◽  
Kristi L. Williams ◽  
...  

ABSTRACT The recently discovered nucleotide binding domain-leucine rich repeat (NLR) gene family is conserved from plants to mammals, and several members are associated with human autoinflammatory or immunodeficiency disorders. This family is defined by a central nucleotide binding domain that contains the highly conserved Walker A and Walker B motifs. Although the nucleotide binding domain is a defining feature of this family, it has not been extensively studied in its purified form. In this report, we show that purified Monarch-1/NLRP12, an NLR protein that negatively regulates NF-κB signaling, specifically binds ATP and exhibits ATP hydrolysis activity. Intact Walker A/B motifs are required for this activity. These motifs are also required for Monarch-1 to undergo self-oligomerization, Toll-like receptor- or CD40L-activated association with NF-κB-inducing kinase (NIK) and interleukin-1 receptor-associated kinase 1 (IRAK-1), degradation of NIK, and inhibition of IRAK-1 phosphorylation. The stable expression of a Walker A/B mutant in THP-1 monocytes results in increased production of proinflammatory cytokines and chemokines to an extent comparable to that in cells in which Monarch-1 is silenced via short hairpin RNA. The results of this study are consistent with a model wherein ATP binding regulates the anti-inflammatory activity of Monarch-1.


2005 ◽  
Vol 281 (9) ◽  
pp. 5694-5701 ◽  
Author(s):  
Chris van der Does ◽  
Chiara Presenti ◽  
Katrin Schulze ◽  
Stephanie Dinkelaker ◽  
Robert Tampé

2003 ◽  
Vol 278 (29) ◽  
pp. 26862-26869 ◽  
Author(s):  
Eva Janas ◽  
Matthias Hofacker ◽  
Min Chen ◽  
Simone Gompf ◽  
Chris van der Does ◽  
...  

2007 ◽  
Vol 189 (23) ◽  
pp. 8636-8642 ◽  
Author(s):  
Remi Bernard ◽  
Annick Guiseppi ◽  
Marc Chippaux ◽  
Maryline Foglino ◽  
François Denizot

ABSTRACT The Bacillus subtilis BceAB ABC transporter involved in a defense mechanism against bacitracin is composed of a membrane-spanning domain and a nucleotide-binding domain. Induction of the structural bceAB genes requires the BceR response regulator and the BceS histidine kinase of a signal transduction system. However, despite the presence of such a transduction system and of bacitracin, no transcription from an unaltered bceA promoter is observed in cells lacking the BceAB transporter. Expression in trans of the BceAB transporter in these bceAB cells restores the transcription from the bceA promoter. Cells possessing a mutated nucleotide-binding domain of the transporter are also no longer able to trigger transcription from the bceA promoter in the presence of bacitracin, although the mutated ABC transporter is still bound to the membrane. In these cells, expression of the bceA promoter can no longer be detected, indicating that the ABC transporter not only must be present in the cell membrane, but also must be expressed in a native form for the induction of the bceAB genes. Several hypotheses are discussed to explain the simultaneous need for bacitracin, a native signal transduction system, and an active BceAB ABC transporter to trigger transcription from the bceA promoter.


Sign in / Sign up

Export Citation Format

Share Document